Trial Profile
Use MR functional imaging techniques to evaluate the efficacy of Endostar combined chemoradiotherapy.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Pemetrexed; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date (31 Dec 2012) added as reported by Chinese Clinical Trial Register.
- 15 Nov 2011 New trial record